UBRETID

This brand name is authorized in Austria, Estonia, Hong Kong, Japan, Netherlands, Poland, Singapore

Active ingredients

The drug UBRETID contains one active pharmaceutical ingredient (API):

1 Distigmine UNII 750F36OP6J - DISTIGMINE BROMIDE

Read about Distigmine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
UBRETID Tablet	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N07AA03	Distigmine	N Nervous system → N07 Other nervous system drugs → N07A Parasympathomimetics → N07AA Anticholinesterases
Discover more medicines within N07AA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1100079, 1100080
Country: HK	Department of Health Drug Office	Identifier(s): 19583
Country: JP	医薬品医療機器総合機構	Identifier(s): 1231014F1054, 1312704Q1024, 1312704Q2020
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 7897
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100068510, 100369127, 100383624
Country: SG	Health Sciences Authority	Identifier(s): 02915P